For today's edition of our upgrade list, we used our website's advanced screening functions to search for UPGRADES to BUY or STRONG BUY with complete forecast and valuation data. They are presented by one-month forecast return. ALL of our upgrades for today are rated STRONG BUY with the exception of Aptevo Therapeutics. Aptevo is rated BUY..
|
Ticker |
Company Name |
Market Price |
Valuation |
Last 12-M Return |
1-M Forecast Return |
1-Yr Forecast Return |
P/E Ratio |
Sector Name |
|
AMSWA |
AMER SOFTWARE A |
16.28 |
54.27% |
62.96% |
1.10% |
13.25% |
48.36 |
Computer and Technology |
|
MB |
MINDBODY INC-A |
41.55 |
40.48% |
64.55% |
1.10% |
13.21% |
N/A |
Computer and Technology |
|
CRCM |
CARE.COM INC |
21.69 |
57.80% |
53.83% |
1.09% |
13.14% |
67.78 |
Consumer Discretionary |
|
NEOG |
NEOGEN CORP |
83.75 |
42.62% |
66.14% |
1.09% |
13.06% |
69.99 |
Medical |
|
APVO |
APTEVO THERAPS |
5.09 |
N/A |
165.10% |
0.68% |
8.11% |
N/A |
Medical |
Care.com, Inc. (CRCM) provides online marketplace for finding and managing family care primarily in the United States and internationally. Its platform provides care needs which consists of child care, senior care and special needs care as well as other non-medical family care needs such as pet care, tutoring and housekeeping and helps caregivers find employment opportunities. Care.com, Inc. is based in Waltham, Massachusetts.
This company had decent results the last time they reported in May. Q1 results showed revenue of $47.3 million, an increase of 9% from $43.4 million in the first quarter of 2017. Net income was $2.7 million, compared to $0.8 million in the first quarter of 2017, an improvement of $1.9 million. GAAP EPS (Diluted) was $0.05, compared to $0.01 in the first quarter of 2017.
“We had a strong first quarter of 2018, with both revenue and EBITDA exceeding our expectations – and generated an incremental $5 million in cash,” said Sheila Lirio Marcelo, Founder, Chairwoman and CEO of Care.com. “As we look ahead to 2018, we will continue to focus on initiatives that we expect will drive long-term profitable growth, with the goal of accelerating our top line in 2019 and beyond.”
ValuEngine updated its recommendation from BUY to STRONG BUY for CARE.COM INC on 2018-07-06. Based on the information we have gathered and our resulting research, we feel that CARE.COM INC has the probability to OUTPERFORM average market performance for the next year. The company exhibits ATTRACTIVE Momentum and Earnings Growth Rate.
You can download a free copy of detailed report on Care.com, Inc. (CRCM) from the link below.
|
ValuEngine Forecast |
||
|
Target |
Expected |
|
|---|---|---|
|
1-Month |
21.93 | 1.09% |
|
3-Month |
22.30 | 2.83% |
|
6-Month |
23.04 | 6.22% |
|
1-Year |
24.54 | 13.14% |
|
2-Year |
26.16 | 20.59% |
|
3-Year |
26.26 | 21.08% |
|
Valuation & Rankings |
|||
|
Valuation |
57.80% overvalued |
Valuation Rank(?) |
 6 |
|
1-M Forecast Return |
1.09% |
1-M Forecast Return Rank |
99 |
|
12-M Return |
53.83% |
Momentum Rank(?) |
90 |
|
Sharpe Ratio |
-0.15 |
Sharpe Ratio Rank(?) |
34 |
|
5-Y Avg Annual Return |
-7.21% |
5-Y Avg Annual Rtn Rank |
30 |
|
Volatility |
48.74% |
Volatility Rank(?) |
33 |
|
Expected EPS Growth |
46.88% |
EPS Growth Rank(?) |
72 |
|
Market Cap (billions) |
0.68 |
Size Rank |
55 |
|
Trailing P/E Ratio |
67.78 |
Trailing P/E Rank(?) |
34 |
|
Forward P/E Ratio |
46.15 |
Forward P/E Ratio Rank |
9 |
|
PEG Ratio |
1.45 |
PEG Ratio Rank |
26 |
|
Price/Sales |
3.82 |
Price/Sales Rank(?) |
29 |
|
Market/Book |
23.48 |
Market/Book Rank(?) |
7 |
|
Beta |
1.07 |
Beta Rank |
33 |
|
Alpha |
0.20 |
Alpha Rank |
83 |
